In ILC/NK cluster 5, we noted a higher frequency of CD62L+ cells among ILC2s in T2 asthma compared to non‐T2 asthma (Figure 2E,F; Supporting Information S1: Figure S4). This evidence concerns the gene SELL and asthma.